Deal Corner
February 10, 2024
NDA represents Max Healthcare Institute Limited in its acquisition of Alexis Multi-Speciality Hospital Private Limited

DEAL BRIEF

Max Healthcare Institute Limited (“Max”) has acquired 100% (one hundred percent) equity stake from the promoters in Alexis Multi-Speciality Hospital Private Limited (‘Alexis’) which operates a Nagpur based JCI & NABH accredited 200 bedded hospital namely ‘Alexis Multispecialty Hospital’.

This acquisition further strengthens Max’s footprint in Western India and will enable provisioning of best-in-class clinical care to all patients in the region.

OUR ROLE

We at Nishith Desai Associates conducted due diligence on Alexis and thereafter, acted as the legal and tax advisors to Max for the documentation and the closing of the acquisition.

DEAL TEAM

Nishchal Joshipura

Harshita Srivastava

Chandrashekar K

Ankit Porwal

Anurag Shah

DUE DILIGENCE TEAM

Darren Punnen

Varsha Rajesh

Palomita Sharma

FURTHER DETAILS ARE AVAILABLE AT

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-crore/articleshow/107546548.cms?from=mdr

https://www.financialexpress.com/business/industry-max-healthcare-announces-acquisition-of-100-stake-in-alexis-hospital-for-rs-412-crore-3388979/

https://www.business-standard.com/companies/news/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-cr-124020900635_1.html

 

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This Hotline provides general information existing at the time of preparation. The Hotline is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this Hotline. It is recommended that professional advice be taken based on the specific facts and circumstances. This Hotline does not substitute the need to refer to the original pronouncements.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.

Deal Corner

February 10, 2024

NDA represents Max Healthcare Institute Limited in its acquisition of Alexis Multi-Speciality Hospital Private Limited

DEAL BRIEF

Max Healthcare Institute Limited (“Max”) has acquired 100% (one hundred percent) equity stake from the promoters in Alexis Multi-Speciality Hospital Private Limited (‘Alexis’) which operates a Nagpur based JCI & NABH accredited 200 bedded hospital namely ‘Alexis Multispecialty Hospital’.

This acquisition further strengthens Max’s footprint in Western India and will enable provisioning of best-in-class clinical care to all patients in the region.

OUR ROLE

We at Nishith Desai Associates conducted due diligence on Alexis and thereafter, acted as the legal and tax advisors to Max for the documentation and the closing of the acquisition.

DEAL TEAM

Nishchal Joshipura

Harshita Srivastava

Chandrashekar K

Ankit Porwal

Anurag Shah

DUE DILIGENCE TEAM

Darren Punnen

Varsha Rajesh

Palomita Sharma

FURTHER DETAILS ARE AVAILABLE AT

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-crore/articleshow/107546548.cms?from=mdr

https://www.financialexpress.com/business/industry-max-healthcare-announces-acquisition-of-100-stake-in-alexis-hospital-for-rs-412-crore-3388979/

https://www.business-standard.com/companies/news/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-cr-124020900635_1.html

 

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This Hotline provides general information existing at the time of preparation. The Hotline is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this Hotline. It is recommended that professional advice be taken based on the specific facts and circumstances. This Hotline does not substitute the need to refer to the original pronouncements.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.